Wellthy Therapeutics raises USD 2.1 million in seed funding
Self-funded until this seed round, Wellthy Therapeutics has spent the last 2 years in clinical pilots and gathering real world evidence of its solution capability
Self-funded until this seed round, Wellthy Therapeutics has spent the last 2 years in clinical pilots and gathering real world evidence of its solution capability